Glazer Capital LLC’s Inozyme Pharma INZY Stock Holding History

Glazer Capital LLC’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,330,220	Closed	-$17.3M	–	326
2025 Q2	$17.3M	Buy	+4,330,220	New	+$10.7M	0.62%	31

Glazer Capital LLC's INZY Position: Q3 2025 in Review

Glazer Capital LLC sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 4,330,220 shares — an estimated $17.3M sold.

Glazer Capital LLC first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $17.3M in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Glazer Capital LLC reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Glazer Capital LLC sold 4,330,220 Inozyme Pharma shares in Q3 2025, an estimated $17.3M.
Glazer Capital LLC first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
Glazer Capital LLC's Inozyme Pharma position peaked at $17.3M in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Glazer Capital LLC's 13F filing for Q3 2025, filed 13 Nov 2025.